Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Reexamination Certificate
2007-03-13
2007-03-13
Whiteman, Brian (Department: 1635)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
C424S093100
Reexamination Certificate
active
10105815
ABSTRACT:
Methods of pre-treating healthy donor's myoblast cultures with growth or trophic factors on transplantation into subjects suffering from myopathic conditions such as muscular dystrophy. Compositions comprising myoblasts and fusion-promoting metalloproteases can be transplanted. Alternatively, myoblasts can be transplanted along with an agent inducing the expression of a fusion-promoting metalloprotease, or a composition comprising genetically-modified myoblasts capable of expressing a fusion-promoting metalloprotease can be transplanted.
REFERENCES:
patent: 5435999 (1995-07-01), Austin
patent: 5833978 (1998-11-01), Tremblay
patent: 6284242 (2001-09-01), Kurachi
patent: WO 91 12329 (1991-08-01), None
patent: WO 96 28541 (1996-09-01), None
Rando et al., The Journal of Cell Biology, 125:1275-1287, 1994.
Huard et al., Muscle & Nerve, 15: 550-560, 1992.
Huard et al., Muscle & Nerve, 17:224-234, 1994.
Ledley et al., Pharmaceutical approach to somatic gene therapy, 1996, Pharmaceutical Research, vol. 13, pp. 1595-1614.
Tremblay et al., Myoblast transplantation: a brief review of the problems and of some solutions, 1997, Basic Appl. Myol., vol. 7, pp. 221-230.
Hodgetts et al., Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or NK1.1+ cells, 2000, Cell Transplantation, vol. 9, pp. 489-502.
Skuk et al., Progress in myoblas transplantation: A potential treatment of dystrophies, 2000, Microscopy Research and Technique, vol. 48, pp. 213-222.
Vaidya et al., Isolation and structural analysis of the rat MyoD gene, 1992, GENE, vol. 116, pp. 223-230.
Anderson, Human gene therapy, 1998, NATURE, vol. 392, pp. 25-30.
Verma et al., Gene therapy-promises, problems and prospects, 1997, NATURE, vol. 389, pp. 239-242.
Kinoshita et al., Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficiency of their transplantation in mdx mice, Muscle & Nerve, Aug. 18, 1995, 834-841 XP000572291.
Crinnion et al., Role of neutrophil-endothelial adhesion in skeletal muscle reperfusion injury, British Journal of Surgery, vol. 83, No. 2, Feb. 1996, pp. 251-254, XP002054086.
Powell, Expression of the metallproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice, Cancer Research, vol. 53, No. 2, Jan. 15, 1993, pp. 417-422, XP002054097.
Overall et al., J. of Biological Chemistry, 265(34): 21141-21151, Dec. 1990.
Rapuano et al., Dev. Biol. 134(2): 271-8, Aug. 1989.
Chin et al. Development, 124:1519-1530, Apr. 1997.
Universite Laval
Whiteman Brian
LandOfFree
Method of in vitro preconditioning healthy donor's... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of in vitro preconditioning healthy donor's..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of in vitro preconditioning healthy donor's... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3771954